CurifyLabs

📍 Helsinki, Finland🗓 Founded 2021👥 43 employees💰 Last funded Jun 2026
Pharmaceutical Manufacturing🌐 curifylabs.com
Website LinkedIn
CurifyLabs is a healthtech company building solutions for automated compounding of personalized medicines in pharmacies and hospitals. We’re transforming a traditionally manual, time-intensive workflow into a streamlined, efficient, and accurate process—helping pharmacists deliver patient-specific therapies with compliance by design. Our Compounding System Solution (CSS) is an automated platform for non-sterile compounding. CSS combines GMP-manufactured excipient bases, compounding robotics inspired by 3D printing, integrated in-process quality control, software, and a comprehensive formulation library—supporting consistent quality, improved efficiency, and better patient access. CSS is in clinical use with customers in Europe and the US, enabling pharmacies and hospital pharmacies to compound faster and more safely, with high standards built into the workflow. CurifyLabs was founded in 2021 by Charlotta Topelius and Niklas Sandler Topelius.
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2021
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Sweden
1
Frequently asked questions
Who invested in CurifyLabs?
CurifyLabs has 1 investors on record on gritt.io, 1 mid-stage.
When did CurifyLabs last raise funding?
The most recent investment in CurifyLabs recorded on gritt.io was in June 2026.
When was CurifyLabs founded?
CurifyLabs was founded in 2021.
What industry is CurifyLabs in?
CurifyLabs operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is CurifyLabs based?
CurifyLabs is headquartered in Helsinki, Finland.